Eluvixtamab (AMG-330)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 00:14, 18 October 2023 by Warner-admin (talk | contribs) (Text replacement - "/CD3 bispecific" to "-CD3 bispecific")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Bispecific T-cell engager antibody that engages CD33 and CD3

Also known as

Code name: AMG-330

Retrieved from "https://hemonc.org/w/index.php?title=Eluvixtamab_(AMG-330)&oldid=79778"